financetom
Business
financetom
/
Business
/
Update: Enbridge Q3 Adjusted Earnings Drop Despite Higher Revenue; 2024 Guidance Confirmed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Enbridge Q3 Adjusted Earnings Drop Despite Higher Revenue; 2024 Guidance Confirmed
Nov 4, 2024 12:13 PM

11:15 AM EDT, 11/01/2024 (MT Newswires) -- (Adds analyst comment)

Enbridge (ENB.TO) said Friday that its adjusted earnings fell even as revenue rose by more than half.

Adjusted earnings, excluding most one-time items, fell to $1.19 billion, or $0.55 per share, from $1.27 billion, or $0.62 per share. S&P Capital IQ forecast Enbridge's ( ENB ) adjusted EPS at $0.56.

Enbridge said the lower adjusted earnings were driven by higher debt principal and rates due to the acquisition of Enbridge Gas Ohio and Enbridge Gas Utah, as well as higher depreciation expense from assets acquired and placed into service last year.

Revenue rose 51% to $14.88 billion from $9.84 billion.

Adjusted Ebitda rose to $4.20 billion from $3.87 billion due to higher revenue on the Mainline system from higher tolls, higher contributions from U.S. Gulf Coast natural gas storage assets, and contributions from recently acquired assets.

"We remain committed to disciplined investment, maintaining a strong balance sheet and growing our dividend," President and CEO Greg Ebel said.

The company reaffirmed its 2024 full year financial guidance. It expects to hit near the top end of its Ebitda guidance range of $17.7 billion to $18.3 billion, and around the midpoint for discounted cash flow per share.

National Bank of Canada following the results maintained its sector-perform on Enbridge shares and its $57.00 price target.

The bank said its rating and price target are based on Enbridge's ( ENB ) risk-adjusted dividend yield of 6.5%, an EV/Free-EBITDA multiple of 13.0x, as well as its DCF/share valuation of $56.75.

"With the company's organic growth backlog up ~$3 billion, we expect a modest bump to our long-term estimates following the company's conference call," National Bank said.

Enbridge shares were last seen up $0.245 to $56.485 on the Toronto Stock Exchange.

Price: 56.50, Change: +0.26, Percent Change: +0.46

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atlantic Union Bankshares CFO Robert Gorman to Retire by March 2026
Atlantic Union Bankshares CFO Robert Gorman to Retire by March 2026
May 26, 2025
07:18 AM EDT, 05/22/2025 (MT Newswires) -- Atlantic Union Bankshares ( AUB ) said Thursday that Executive Vice President and Chief Financial Officer Robert M. Gorman plans to retire by March 31, 2026. Gorman will remain in his roles until a successor is named or his retirement date, whichever is earlier, the company said. Gorman, who has been CFO since...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
ANI Pharmaceuticals Launches Phase 4 Trial of Cortrophin Gel for Acute Gout Flares
ANI Pharmaceuticals Launches Phase 4 Trial of Cortrophin Gel for Acute Gout Flares
May 26, 2025
07:17 AM EDT, 05/22/2025 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said Thursday it initiated a phase 4 trial at Massachusetts General Hospital to evaluate the safety and efficacy of two dosing levels of purified Cortrophin gel in treating acute gout flares. The company said Cortrophin gel is approved for short-term use as an adjunct therapy during acute episodes...
Neo Performance Materials exits China separation facilities
Neo Performance Materials exits China separation facilities
May 26, 2025
May 22 (Reuters) - Canadian rare earths company Neo Performance Materials ( NOPMF ) said on Thursday it has exited from its China separation facilities, helping it reduce its exposure to volatile pricing and free up working capital and cash balances. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved